Phase 4 N=96 A Comparative Evaluation of the Performance and Fit of Pediatric Face Masks
Healthy
Primary: Change From Baseline in Carbon Dioxide Levels — -0.07; -0.79 mmHg
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=22 Plerixafor for Stem Cell Mobilization in Normal Donors
Blood And Marrow Transplantation
Primary: Summary of Most Common Toxicity: Donor Safety in Mobilizing Peripheral Blood Progenitor Cells (PBPC) — 1; 2; 2; 2 adverse events
N/A N=40 Chronotropic Incompetence in Patients With HFpEF
Heart Failure
Primary: Cardiac Beta-receptor Sensitivity — 0.254; 0.156; 0.365 beats per ng/kg/min ISO
N/A N=20 Comparison of Botulinum Toxin Injections in Forearm FLexor Plus EXtensor Muscles vs. Flexor Muscles Alone for Treatment of Essential Hand Tremor(FLEX-D ET)
Essential Tremor
Primary: Difference in the 6 Week Post Injection Patient Global Impression of Improvement Scale (PGIS) Between Flexors Along and Flexors Plus Extensors Groups. — 1.2; 2.2 score…
Early Phase 1 N=116 18F-DCFBC PET/CT in Prostate Cancer
Prostatic Neoplasms · Prostate Cancer
Primary: Number of Participants With Local Recurrence, Lymph Node Metastases or Distant Metastatic Sites Detected by…
N/A N=41,193 Strategies and Opportunities to Stop Colon Cancer in Priority Populations
Colorectal Cancer
Primary: FIT Completion — 10.4; 13.9 Model based percentage of participants — p=.05
Phase 2 N=52 Study to Demonstrate Cognitive Enhancing Effects of BF2.649
Schizophrenia
Primary: Changes in Delayed Recall From Baseline to 12 Weeks — 40.2; 43.4 t-score
Phase 2 N=104 Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Dyspepsia · Diabetes Mellitus With Gastrointestinal Symptoms
Primary: Mean Intestinal Chemosensitivity to Lipids Perfusion — 0.22; 0.36; 0.55; 0.65 score on a scale — p=0.06
N/A N=20 Effects of Cardiac Rehabilitation for Individuals With Transient Ischemic Attack
Transient Ischemic Attack
Primary: Functional Walk Test — 498.4; 503.2; 564.2 meters — p==0.06
N/A N=28 INVSENSOR00013 Respiratory Rate Clinical Performance Study
Healthy
Primary: RRp Arms of Sensor Accuracy — 1.2 respiration per minute (RPM)
Phase 4 N=226 Stress Neuroadaptation in Tobacco Dependence
Nicotine Dependence
Primary: Overall Stressor Reactivity — 25.1; 22.5; 32.3; 16.9 microvolts
Phase 3 N=288 MSB11022 in Moderate to Severe Rheumatoid Arthritis
Moderate to Severe Rheumatoid Arthritis
Primary: Percentage of Participants With Treatment-emergent Adverse Events of Special Interest (AESI) — 4.2; 5.5 Percentage of Participants
Phase 1 N=30 Relative Bioavailability Study to Investigate and to Compare Two Different Formulations of Hyoscine Butylbromide in Healthy Male and Female Volunteers
Healthy
Primary: Maximum Measured Concentration of the Hyoscine Butylbromide in Plasma (Cmax) — 70.3; 77.1 Picogram/millilitre [pg/mL]
Phase 2 N=3 Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization
Liver Cancer · Liver Neoplasm · Hepatocellular Carcinoma
Primary: Number of Participants for Which Uptake of [18F]-FMISO Was Successful and Hypoxic Tumors Were Observed During PET Scan Imaging Post TACE Procedure — 0 Participants
N/A N=56 Study to Image the Esophagus Using the OFDI Capsule
Barrett's Esophagus · Eosinophilic Esophagitis
Primary: Feasibility of OFDI Imaging in Subjects Swallowing the OFDI Capsule — 56 Participants